Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2021-01-22 | 2021-09-02 | 132261 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-22 | 2021-04-21 | 132264 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2021-01-22 | 2021-02-11 | 132267 |
OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2021-01-22 | 2021-03-18 | 132270 |
TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2021-01-22 | 2021-03-11 | 132273 |
ACT RALOXIFENE | 60MG | TABLET | Resolved | 2021-01-22 | 2021-05-06 | 132276 |
TEVA-TEMOZOLOMIDE | 5MG | CAPSULE | Resolved | 2021-01-22 | 2021-06-03 | 132279 |
TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132282 |
TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132285 |
TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132288 |
ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2021-01-22 | 2021-02-12 | 132291 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2021-01-22 | 2021-02-12 | 132294 |
ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-22 | 2021-02-12 | 132297 |
FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-01-28 | 2021-02-05 | 132630 |
TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-03-18 | 132633 |
TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-28 | 2021-02-05 | 132639 |
TREANDA | 100MG | POWDER FOR SOLUTION | Resolved | 2021-01-28 | 2021-02-11 | 132644 |
TEVA-TOPIRAMATE | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-11 | 132649 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-01-28 | 2021-05-20 | 132652 |
TEVA-CANDESARTAN/HCTZ | 32MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132657 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |